Azathioprine in the therapy of paediatric inflammatory bowel disease – part I: treatment indications, dosing and thiopurine-related adverse events
Review articleGastroent Hepatol 2021; 75(6): 500–507. doi: 10.48095/ccgh2021500
SummaryLiteraturepdf Kristýna Pospíšilová, Jiří BronskýAzathioprine in the therapy of paediatric inflammatory bowel disease – part II: pharmacodynamics, pharmacokinetics, and the possibilities of measuring its metabolites in clinical practice
Review articleGastroent Hepatol 2021; 75(6): 508–514. doi: 10.48095/ccgh2021508
SummaryLiteraturepdf Kristýna Pospíšilová, Jiří Bronský